Innova MicroLab arises from the need to address an existing global health problem, resistance to antimicrobial drugs, and prevent the possibility of infections becoming uncontrollable for this reason. The project envisages the development of two fully automated technology platforms that will improve the treatments applied to patients.
This project has a total budget of €5,700,000, of which €4,560,000 will be allocated for Public Procurement of Innovationtenders that address the challenges identified. This funding is supported by galician, national and european public institutions and is 80% co-financed by the European Regional Development Fund (ERDF).